Evolent Health (NYSE: EVH) reported Q3 EPS of $0.05, $0.06 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $479.53 million versus the consensus estimate of $467.49 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.